Coronavirus, the Abbott company will provide the first 150,000 serological tests to the government

As anticipated in the afternoon by ilfattoquotidiano.it, it will not be the Italian company DiaSorin to supply the first 150 thousand serological tests to the government. The task will be up to the American company Abbott, who will accompany the executive from the beginning of ‘phase 2’ with tests to estimate the percentage of Italians affected by the virus, many of whom could – but it is not scientifically of course – also having developed antibodies. They will start next May 4 nationally, on a first sample of 150 thousand peopleblood tests to define if a person has been infected, even unconsciously. Government and experts will thus add an important element in the post-lockdown strategy, which will allow us to understand the level of diffusion of the coronavirus in the country and plan the timing of the gradual return to activities.

To offer for free i kit it will be there colossus pharmaceutical American ‘Abbott’, selected four days in advance among the 72 participants in the tender called by the government just over a week ago. It is therefore the “best solution on the market today”, explains il Commissioner for the emergency, Domenico Arcuri. The experimentation will start in the laboratories of the various regions and will concern specific population samples based on the categories Istat is Inail, taking into account work profile, gender and six age groups. The first results will occur already from the first week and in those following a possible is expected extension the supply of kits, reagents and Consumable of the same type, with another 150 thousand tests for a total of 300 thousand.

“There is not one in the world that gives 100% of the response – Arcuri adds – we had put in place basis of the race a result that it were equal 95%, for those who have won it, it is greater than 95% and we trust that it is a very important test “. Percentages that played a role determinant in the choice of the company selected for testing, which on the typology test complied with the required criteria – all close to 100% – of ‘specificity’, i.e. suitability, ‘sensitivity’, ‘applicability’ on a large scale and ‘speed’ of reply. The investigation of seroprevalence in some northern territories, to which they have been submitted first several workers among the health personnel, she had already left on her own a few days ago: the front row Lombardy, who with Governor Fontana had announced “a” driving license of immunity‘For people who have had this disease and who have a sufficient number of antibodies to guarantee the coverage“.

To brake on the advance times was instead the Technical-scientific committee for the emergency, waiting for the push of the new positives to finally end, for to understand better the epidemiology of patients. A situation, the latter, that is consolidate further precisely in view of the beginning of May. And nationwide tests that depart in a dozen days – at least in this first trial step – they are not aiming to provide ‘immunity licenses’. On this good part of community scientific seems to agree and in line with the WHO, according to which “it will still take time”. The Organization World della Sanità recalled that there is still no scientific evidence that people recovered from Covid-19 have antibodies that protect against a second infection, explaining in a document that “at this point in the pandemic there is not enough evidence on the effectiveness of immunity given by antibodies to ensure the accuracy of an ‘immunity passport’ or a ‘certificate of freedom from risk “.

Previous article

OnePlus 8 and 8 Pro, prices and specifications for Italy